New Canaan Funding Mezzanine VII SBIC, LP; Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest, 79930 [2022-28213]
Download as PDF
79930
Federal Register / Vol. 87, No. 248 / Wednesday, December 28, 2022 / Notices
received will be posted without change.
Persons submitting comments are
cautioned that we do not redact or edit
personal identifying information from
comment submissions. You should
submit only information that you wish
to make available publicly. All
submissions should refer to File
Number SR–MRX–2022–29 and should
be submitted on or before January 18,
2023.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.56
Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2022–28199 Filed 12–27–22; 8:45 am]
BILLING CODE 8011–01–P
SMALL BUSINESS ADMINISTRATION
[License No. 05/05–0344]
ddrumheller on DSK6VXHR33PROD with NOTICES
Convergent Capital Partners IV, LP;
Notice Seeking Exemption Under
Section 312 of the Small Business
Investment Act, Conflicts of Interest
Notice is hereby given that
Convergent Capital Partners IV, LP,
9855 West 78th Street, Suite 320, Eden
Prairie, MN 55344, a Federal Licensee
under the Small Business Investment
Act of 1958, as amended (‘‘the Act’’), in
connection with the financing of a small
concern, has sought an exemption under
section 312 of the Act and 13 CFR
107.730, Financings which Constitute
Conflicts of Interest of the Code of
Federal Regulations. Convergent Capital
Partners IV, LP, is seeking a written
exemption from SBA for a proposed
financing to Optimum Healthcare IT,
LLC, 1300 Marsh Landing Parkway,
Jacksonville Beach, FL 32250.
The financing is brought within the
purview of 13 CFR 107.730(a)(4) of the
Code of Federal Regulations because
proceeds from the financing will
discharge the obligation of Convergent
Capital Partners III, LP, an Associate by
virtue of Common Control as defined at
13 CFR 107.50.
Notice is hereby given that any
interested person may submit written
comments on this transaction within
fifteen days of the date of this
publication to the Associate
Administrator, Office of Investment and
Innovation, U.S. Small Business
56 17
Administration, 409 Third Street SW,
Washington, DC 20416.
Administration, 409 Third Street SW,
Washington, DC 20416.
Bailey DeVries,
Associate Administrator, Office of Investment
and Innovation, U.S. Small Business
Administration.
Bailey DeVries,
Associate Administrator, Office of Investment
and Innovation, U.S. Small Business
Administration.
[FR Doc. 2022–28212 Filed 12–27–22; 8:45 am]
[FR Doc. 2022–28213 Filed 12–27–22; 8:45 am]
BILLING CODE P
BILLING CODE P
SMALL BUSINESS ADMINISTRATION
[Public Notice: 11952]
[License No. 04/04–0349]
New Canaan Funding Mezzanine VII
SBIC, LP; Notice Seeking Exemption
Under Section 312 of the Small
Business Investment Act, Conflicts of
Interest
Notice is hereby given that New
Canaan Funding Mezzanine VII SBIC,
LP, 305 Fifth Avenue South, Suite 204
Naples, FL 34102, a Federal Licensee
under the Small Business Investment
Act of 1958, as amended (‘‘the Act’’), in
connection with the financing of a small
concerns, has sought an exemption
under section 312 of the Act and 13 CFR
107.730, Financings which Constitute
Conflicts of Interest of the Code of
Federal Regulations. New Canaan
Funding Mezzanine VII SBIC, LP is
proposing to provide financing to
Safemark Inc., 200 W. Sand Lake Rd.,
Suite 800, Orlando, FL to support the
company’s growth.
The proposed transaction is brought
within the purview of 13 CFR 107.730
of the Code of Federal Regulations
because New Canaan Funding
Mezzanine V SBIC, LP and New Canaan
Funding Mezzanine V, LP, Associates of
New Canaan Funding Mezzanine VII
SBIC, LP, by virtue of Common Control
as defined at 13 CFR 107.50, hold
investments in Safemark, Inc. which
will be discharged. In addition, New
Canaan Funding Mezzanine VII SBIC,
LP and its Associates did not previously
invest in Safemark, Inc. at the same time
and on the same terms and conditions
as the proposed financing to Safemark,
Inc.
Therefore, the proposed transaction is
considered self-deal pursuant to 13 CFR
107.730 and requires a regulatory
exemption. Notice is hereby given that
any interested person may submit
written comments on the transaction
within fifteen days of the date of this
publication to Associate Administrator
for Investment, U.S. Small Business
CFR 200.30–3(a)(12).
VerDate Sep<11>2014
18:26 Dec 27, 2022
Jkt 259001
DEPARTMENT OF STATE
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
U.S. Department of State Advisory
Committee on Private International
Law: Public Meeting on the Final
Report of the Experts Group on
Parentage/Surrogacy Project of the
Hague Conference on Private
International Law (HCCH).
The Department of State’s Advisory
Committee on Private International Law
(ACPIL) will hold a virtual meeting to
discuss the Hague Experts Group Final
Report on Parentage/Surrogacy Project
on Wednesday February 1, 2023. The
meeting will be held in WebEx. The
program is scheduled to run from 1 p.m.
to 4 p.m.
The meeting will discuss the Final
Report of the Experts’ Group regarding
the feasibility of one or more private
international law instruments on legal
parentage. The Final Report has been
made available on the HCCH website at
https://assets.hcch.net/docs/6d8eeb81ef67-4b21-be42-f7261d0cfa52.pdf. The
Report will be considered by the
Council on General Affairs and Policy
(CGAP) in March 2023, at which CGAP
is expected to decide on whether future
work on the project should be pursued.
This Report presents the HCCH Experts’
Group on Parentage/Surrogacy analysis
and main conclusions on the feasibility
of the core aspects of possible options
for two separate binding legal
instruments on legal parentage: one on
legal parentage in general, and another
on legal parentage established as a result
of an international surrogacy
arrangement (ISA) specifically. The
purpose of the public meeting is to
obtain the views of concerned
stakeholders on the matters presented in
the Report.
Members of the public may attend
this virtual session and will be
permitted to participate in the
discussion. Virtual attendance is limited
to 100 persons, so each member of the
public that wishes to attend this session
must provide: Name, contact
information, and affiliation to pil@
state.gov, not later than January 23,
2023. When you register, please indicate
whether you require captioning. The
E:\FR\FM\28DEN1.SGM
28DEN1
Agencies
[Federal Register Volume 87, Number 248 (Wednesday, December 28, 2022)]
[Notices]
[Page 79930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28213]
-----------------------------------------------------------------------
SMALL BUSINESS ADMINISTRATION
[License No. 04/04-0349]
New Canaan Funding Mezzanine VII SBIC, LP; Notice Seeking
Exemption Under Section 312 of the Small Business Investment Act,
Conflicts of Interest
Notice is hereby given that New Canaan Funding Mezzanine VII SBIC,
LP, 305 Fifth Avenue South, Suite 204 Naples, FL 34102, a Federal
Licensee under the Small Business Investment Act of 1958, as amended
(``the Act''), in connection with the financing of a small concerns,
has sought an exemption under section 312 of the Act and 13 CFR
107.730, Financings which Constitute Conflicts of Interest of the Code
of Federal Regulations. New Canaan Funding Mezzanine VII SBIC, LP is
proposing to provide financing to Safemark Inc., 200 W. Sand Lake Rd.,
Suite 800, Orlando, FL to support the company's growth.
The proposed transaction is brought within the purview of 13 CFR
107.730 of the Code of Federal Regulations because New Canaan Funding
Mezzanine V SBIC, LP and New Canaan Funding Mezzanine V, LP, Associates
of New Canaan Funding Mezzanine VII SBIC, LP, by virtue of Common
Control as defined at 13 CFR 107.50, hold investments in Safemark, Inc.
which will be discharged. In addition, New Canaan Funding Mezzanine VII
SBIC, LP and its Associates did not previously invest in Safemark, Inc.
at the same time and on the same terms and conditions as the proposed
financing to Safemark, Inc.
Therefore, the proposed transaction is considered self-deal
pursuant to 13 CFR 107.730 and requires a regulatory exemption. Notice
is hereby given that any interested person may submit written comments
on the transaction within fifteen days of the date of this publication
to Associate Administrator for Investment, U.S. Small Business
Administration, 409 Third Street SW, Washington, DC 20416.
Bailey DeVries,
Associate Administrator, Office of Investment and Innovation, U.S.
Small Business Administration.
[FR Doc. 2022-28213 Filed 12-27-22; 8:45 am]
BILLING CODE P